Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why
In brief
Sector rally on mRNA cancer therapy news lifts biotech names, but RXRX’s insider share sale tempers its upside.
ClearTape summarizes context in-app. For the full publisher article, use Read original source above.